Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if abraxane can help to control
colorectal and/or small bowel cancer. The safety of this drug will also be studied.
Abraxane is designed to block cancer cells from dividing, which may cause them to die.